This is an archived version of the Handbook. For the current version, please go to or search for this chapter here.

15.11  References

Aguiar-Ibanez 2005
Aguiar-Ibanez R, Nixon J, Glanville J, Craig D, Rice S, Christie J, Drummond MF. Economic evaluation databases as an aid to healthcare decision-makers and researchers. Expert Review of Pharmacoeconomics and Outcomes Research 2005; 5: 721-722.

Azimi 1998
Azimi NA, Welch HG. The effectiveness of cost-effectiveness analysis in containing costs. Journal of General Internal Medicine 1998; 13: 664-669.

Bell 2006
Bell CM, Urbach DR, Ray JG, Bayoumi A, Rosen AB, Greenberg D, Neumann PJ. Bias in published cost effectiveness studies: systematic review. BMJ 2006; 332: 699-703.

Beney 2000
Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database of Systematic Reviews 2000, Issue 3. Art No: CD000336.

Best 2000
Best L, Simmonds P, Baughan C, Buchanan R, Davis C, Fentiman I, George S, Gosney M, Northover J, Williams C, Colorectal Meta-analysis Collaboration. Palliative chemotherapy for advanced or metastatic colorectal cancer. Cochrane Database of Systematic Reviews 2000, Issue 2. Art No: CD001545.

Birks 2006
Birks J, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art No: CD001190.

Briggs 2006
Briggs A, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation. Oxford (UK): Oxford University Press, 2006.

Brown 2007
Brown SR, Nelson RL. Surgery for faecal incontinence in adults. Cochrane Database of Systematic Reviews 2007, Issue 2. Art No: CD001757.

Campbell 2007
Campbell H, Briggs A, Buxton M, Kim L, Thompson S. The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm. Journal of Health Services Research and Policy 2007; 12: 11-17.

Cochrane 1972
Cochrane AL. Effectiveness and Efficiency: Random Reflections on Health Services. London (UK): Nuffield Provincial Hospitals Trust, 1972.

Cooper 2005
Cooper N, Coyle D, Abrams K, Mugford M, Sutton A. Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997. Journal of Health Services Research and Policy 2005; 10: 245-250.

Craig 2007
Craig D, Rice S. CRD Report 6: NHS Economic Evaluation Database Handbook (3rd edition). York (UK): Centre for Reviews and Dissemination, University of York, 2007.

Donaldson 2002
Donaldson C, Mugford M, Vale L. From effectiveness to efficiency: an introduction to evidence-based health economics. In: Donaldson C, Mugford M, Vale L (editors). Evidence-based Health Economics: From Effectiveness to Efficiency in Systematic Reviews. London (UK): BMJ Books, 2002.

Drummond 1992
Drummond MF. Economic evaluation of pharmaceuticals: science or marketing? Pharmacoeconomics 1992; 1: 8-13.

Drummond 1996
Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996; 313: 275-283.

Drummond 2001
Drummond M, Pang F. Transferability of economic evaluation results. In: Drummond M, McGuire A (editors). Economic Evaluation in Health Care: Merging Theory with Practice. New York (NY): Oxford University Press, 2001.

Drummond 2002
Drummond M. Evidence-based medicine meets economic evaluation – an agenda for research. In: Donaldson C, Mugford M, Vale L (editors). Evidence-based Health Economics: From Effectiveness to Efficiency in Systematic Reviews. London (UK): BMJ Books, 2002.

Drummond 2005
Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes (3rd edition). Oxford (UK): Oxford University Press, 2005.

Evers 2005
Evers S, Goossens M, de Vet H, van Tulder M, Ament A. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. International Journal of Technology Assessment in Health Care 2005; 21: 240-245.

Fayter 2007
Fayter D, Nixon J, Hartley S, Rithalia A, Butler G, Rudolf M, Glasziou P, Bland M, Stirk L, Westwood M. A systematic review of the routine monitoring of growth in children of primary school age to identify growth-related conditions. Health Technology Assessment 2007; 11: 22.

Freemantle 1997
Freemantle N, Mason J. Publication bias in clinical trials and economic analyses. Pharmacoeconomics 1997; 12: 10-16.

Friedberg 1999
Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennett CL. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA 1999; 282: 1453-1457.

Gamble 2006
Gamble CL, Williamson PR, Marson AG. Lamotrigine versus carbamazepine monotherapy for epilepsy. Cochrane Database of Systematic Reviews 2006, Issue 1. Art No: CD001031.

Gilbody 1999
Gilbody SM, Petticrew M. Rational decision-making in mental health: the role of systematic reviews. Journal of Mental Health Policy and Economics 1999; 2: 99-106.

Hutubessy 2003
Hutubessy R, Chisholm D, Edejer TT. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Effectiveness and Resource Allocation 2003; 1: 8.

Kumaranayake 2002
Kumaranayake L, Walker D. Cost-effectiveness analysis and priority setting: Global approach without local meaning? In: Lee K, Buse K, Fustukian S (editors). Health Policy in a Globalising World. Cambridge (UK): Cambridge University Press, 2002.

Lavis 2005
Lavis J, Davies H, Oxman A, Denis JL, Golden-Biddle K, Ferlie E. Towards systematic reviews that inform health care management and policy-making. Journal of Health Services Research and Policy 2005; 10 Suppl 1: 35-48.

Lexchin 2003
Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003; 326: 1167-1170.

Maynard 2000
Maynard A, Kanavos P. Health economics: an evolving paradigm. Health Economics 2000; 9: 183-190.

Miners 2005
Miners AH, Garau M, Fidan D, Fischer AJ. Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study. BMJ 2005; 330: 65.

Napper 2005
Napper M, Varney J. Etext on Health Technology Assessment (HTA) Information Resources. Chapter 11: Health Economics Information. Available from: (accessed 1 January 2008).

Neumann 2005
Neumann PJ, Greenberg D, Olchanski NV, Stone PW, Rosen AB. Growth and quality of the cost-utility literature, 1976-2001. Value in Health 2005; 8: 3-9.

Philips 2004
Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technology Assessment 2004; 8: 36.

Rennie 2000
Rennie D, Luft HS. Pharmacoeconomic analyses: making them transparent, making them credible. JAMA 2000; 283: 2158-2160.

Rodgers 2006
Rodgers M, Nixon J, Hempel S, Aho T, Kelly J, Neal D, Duffy S, Ritchie G, Kleijnen J, Westwood M. Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation. Health Technology Assessment 2006; 10: 18.

Samuelson 2005
Samuelson PA, Nordhaus WD. Economics. London (UK): McGraw-Hill, 2005.

Sculpher 2004
Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technology Assessment 2004; 8: 49.

Shemilt 2007
Shemilt I, Mugford M, Byford S, Drummond M, Eisenstein E, Knapp M, Mallender J, McDaid D, Vale L, Walker D. Where does economics fit in? A review of economics in Cochrane Reviews.
15th Cochrane Colloquium, Sau Paulo (Brazil), 2007.

Song 2000
Song F, Eastwood AJ, Gilbody S, Duley L, Sutton AJ. Publication and related biases. Health Technology Assessment 2000; 4: 10.

Weinstein 2003
Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices - Modeling studies. Value in Health 2003; 6: 9-17.

Williams 1987
Williams A. Health economics: The cheerful face of the dismal science? In: Williams A (editor). Health and Economics. London (UK): Macmillan, 1987.

Zarnke 1997
Zarnke KB, Levine MA, O'Brien BJ. Cost-benefit analyses in the health-care literature: don't judge a study by its label. Journal of Clinical Epidemiology 1997; 50: 813-822.